TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 17, 2026 · CHIEF FINANCIAL OFFICER Cline Christopher R. sold 50.51K shares at $62.34/share ($3.1M); exercised options for 40K shares

CHIEF FINANCIAL OFFICER Cline Christopher R. sold 50.51K shares at $62.34/share ($3.1M); exercised options for 40K shares

xslF345X06/form4-09182026_010929.xml

xslF345X06/form4-09182026_010929.xmlSEC.gov

Graphics and non-inline formats (not embedded below).